Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

CellCentric at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

CellCentric exhibits at Booth 301, 305 at ASH 2026 in New Orleans. CellCentric supports a symposium on relapsed and refractory multiple myeloma, run by PeerView Institute for Medical Education. It looks at how to sequence T-cell engagers, newer CAR-T therapies and drugs that work in new ways.

OrganizationASH 2026 Attendance
CellCentric
Cambridge, United Kingdom
cellcentric.com
Biotech
Biotechnology company developing inobrodib, an oral p300/CBP inhibitor, for multiple myeloma and other cancers.
Booth
Exhibiting at Booth 301, 305
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
Next in Line for Relapsed/Refractory Myeloma: Sequencing Strategies With T-Cell Engagers, Next-Generation CAR-T, and Innovative MOAs
Sequencing relapsed myeloma treatments as next-generation CAR-T, multi-target T-cell engagers, and new drug classes arrive, plus managing their toxicity.
Symposium hosted by PeerView Institute for Medical Education
Hilton New Orleans Riverside · Grand Ballroom CD
Myeloma · New drugs

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CellCentric

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction